FGF2 and neoplasm: In these conditions, both tumor cells and host endothelial cells can increase the expression of proangiogenic: vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), basic fibroblast growth factor (bFGF), and transforming growth factor (TGF-β) [13–17].